Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
CVS Health Profits Hit $2 Billion As Company Benefits From Obamacare And New Businesses
07:16am, Wednesday, 07'th Feb 2024
CVS Health reported net income of $2 billion thanks to double-digit percentage growth in the company's healthcare benefits and services businesses that included contributions from a big boost in Obama
CVS' stock slips after earnings beat by a wide margin but full-year outlook was cut due to higher medical costs
06:52am, Wednesday, 07'th Feb 2024
Shares of CVS Health Corp. CVS, +1.82% fell 0.3% in premarket trading Wednesday, after the drugstore chain and health care services company's fourth-quarter results beat expectations by wide margins,
CVS cuts 2024 profit forecast on elevated medical costs
06:40am, Wednesday, 07'th Feb 2024
CVS Health lowered its adjusted profit forecast for 2024 on Wednesday after an increase in medical care among older adults in the United States drove up fourth-quarter costs at its insurance business.
CVS beats estimates, but cuts full-year profit outlook on higher medical costs
06:31am, Wednesday, 07'th Feb 2024
The company lowered its 2024 adjusted earnings forecast to at least $8.30 per share, down from a previous guidance of at least $8.50 per share.
The 3 Most Undervalued S&P 500 Stocks to Buy in February 2024
09:41pm, Tuesday, 06'th Feb 2024
Since betting on the individual companies of the Standard and Poor's 500 offers a solid chance for long-term profitability, it stands to reason that going for undervalued S&P 500 stocks could potentia
CVS Health Earnings Are Soon. Medicare Advantage Will Be in Focus.
05:30pm, Tuesday, 06'th Feb 2024
The company is a major player in the Medicare Advantage business, along with Humana and UnitedHealth.
Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now
09:51am, Tuesday, 06'th Feb 2024
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
The 7 Most Undervalued Large-Cap Stocks to Buy in February 2024
06:35am, Tuesday, 06'th Feb 2024
The “Magnificent Seven” stocks may garner the lion's share of market attention right now, but while there may be strong potential with some of “Mag 7” names, check out opportunities making far
The 3 Most Undervalued Long-Term Stocks to Buy in February 2024
06:40pm, Monday, 05'th Feb 2024
As we enter February 2024, the stock market continues to power ahead, led by Big Tech. However, pockets of overvaluation are appearing, especially with the technology sector trading at 27.5 times the
Exploring Analyst Estimates for CVS Health (CVS) Q4 Earnings, Beyond Revenue and EPS
10:21am, Friday, 02'nd Feb 2024
Evaluate the expected performance of CVS Health (CVS) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metri
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know
06:50pm, Thursday, 01'st Feb 2024
In the latest trading session, CVS Health (CVS) closed at $73.92, marking a -0.61% move from the previous day.
CVS Health (CVS) Earnings Expected to Grow: Should You Buy?
11:05am, Wednesday, 31'st Jan 2024
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wall Street Favorites: 3 Undervalued Stocks With Strong Buy Ratings for January 2024
03:36pm, Tuesday, 30'th Jan 2024
While some of the heavily hyped enterprises of last year continue to do well this month, investors ought to consider ideas for undervalued stocks January 2024. True, nothing technically stops a securi
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
10:06am, Tuesday, 30'th Jan 2024
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Is the Worst Over for CVS Health Stock?
03:49pm, Monday, 29'th Jan 2024
CVS Health Corp (NYSE:CVS) stock was last seen up 0.6% at $73.40, extending a bounce off the $70 level.
